Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report

  • ID: 2357063
  • November 2012
  • Region: Global
  • 200 Pages
  • NeuroInsights
1 of 4


  • Aastrom
  • Buck Institute
  • Essential Therapeutics
  • Layton Bioscience
  • Neurotech Pharmaceuticals
  • Sound Pharmaceuticals
  • MORE

An Industry Insider Report on Innovative Research and Development in Stem Cell Technology for the Central Nervous System

Stem cell approaches in neurology and psychiatry is the focus of a new report released today by NeuroInsights, the neurotech market authority. The industry insider report on innovative research and development in stem cell technology for the brain and nervous system provides unique insights into the key players, cutting edge science and investment opportunities in this rapidly advancing field.

Stem cell companies focused on the central nervous system (CNS) have the potential to address some of the largest unmet healthcare markets including: Alzheimer's disease, amyotrophic lateral sclerosis, depression, hearing loss, Huntington's disease, lysosomal storage disorders, macular degeneration, multiple sclerosis, Parkinson's disease, retinal disorders, spinal cord injury, stroke, traumatic brain injury, and other brain and nervous system disorders.

"There continues to be progress in the development of neuroregenerative treatments resulting in new investment opportunities for the informed investor," said Casey Lynch Managing Director of NeuroInsights. READ MORE >

Note: Product cover images may vary from those shown
2 of 4


  • Aastrom
  • Buck Institute
  • Essential Therapeutics
  • Layton Bioscience
  • Neurotech Pharmaceuticals
  • Sound Pharmaceuticals
  • MORE

1: Introduction
Defining Stem Cell Players and Markets
CHART: Stem Cell Industry Taxonomy
- Therapeutics
- Drug Discovery Tools
- Stem Cell Banking

2: Stem Cell Approaches
Science of Transplantation
Controlling Immune Rejection and Infection
Sources and Harvesting of Stem Cells
- Embryonic Stem Cells
- Fetal Stem Cells
- Adult Stem Cells
- Stimulation of Endogenous Stem Cells
- TABLE: Advantages and Disadvantages of Approach by Company
Scientific Challenges and Advances in Neuro Stem Cell Therapy

3: Trends and Drivers
CHART: Economic Burden of Stem Cell Related Indications
Public Policy and Emerging Stem Cell Regions
TABLE: Regional distribution of Stem Cell Companies
Political Trends
MAP: Global Stem Cell Policy
CHART: International Funding of Stem Cell Research
Distribution of Stem Cell Research Centers
State Funded Initiatives Draw Companies
Regulatory Trends
- FDA Approval Process
Medical Tourism

4: Treatments in Development
Market Opportunities in Neurology, Psychiatry and Sensory Disorders
- CHART: Indications for Stem Cell Treatments, Number of People, US and WW
- TABLE: Treatments in Development by Company and Indication
Neurodegenerative Diseases
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Parkinson's Disease and Syndrome
Demyelinating disorders
- Multiple sclerosis
Sensory disorders
- Retinal disorders
- Hearing loss
Traumatic injury
- Spinal Cord Injury (SCI)
- Stroke
Other CNS diseases

5: Investment Risk and Opportunity
Private Investment in Stem Cells
- TABLE: Business Models in Stem Cells from Low to High Risk
- TABLE: Recent Exits in Stem Cells
Public Market Performance
- TABLE: Stem Cell Company Stock Performance and Fundamentals
Case Studies: What Can Go Wrong?
- Case Study 1: Layton Bioscience Inc.
- Case Study 2: BresaGen Ltd.

6: 25 Trendsetters for 2013
Advanced Cell Technology, Inc.
Athersys, Inc.
Biotime Acquisition Corp.
BrainStorm Cell Therapeutics, Inc.
California Stem Cell, Inc.
Cell Cure Neurosciences, Ltd.
DaVinci Biosciences
Fate Therapeutics
International Stem Cell Corp.
Neusentis (Pfizer)
Neuralstem, Inc.
NeuroGeneration, Inc.
NeuroNova AB (Newron)
NsGene A/S
Q Therapeutics
ReNeuron Group plc
RhinoCyte, Inc.
StemCell Technologies, Inc.
Stem Cell Therapeutics
StemCells, Inc.

Note: Product cover images may vary from those shown
3 of 4

- Aastrom
- Advanced Biohealing
- Advanced Cell Technology
- Aldagen
- AmCyte
- Angel Biotechnology
- AnorMed
- Arcos
- ArunA Biomedical
- AstraZeneca
- Athersys
- Bayer
- BD Biosciences
- Bedford Stem Cell Research Foundation
- Beike
- Biocompatibles
- BioEden
- Biogen Idec
- Bio-Matrix
- Biotime
- BioTime Acquisition Corporation
- Bluebird bio
- BrainCells
- BrainStorm Cell Therapeutics
- Buck Institute
- California Stem Cell
- Casey Eye Institute
- Cell Cure
- Cellartis
- CellMed
- CellSeed
- CellzDirect
- Celvive
- Cerebrotech
- Ceregene
- Cord Blood Registry
- CordBlood America
- Cornell
- Cryobanks
- Cryo-Cell International Inc
- CyThera
- Cytomedix
- Cytori
- DaVinci Biosciences
- Double U Fund
- ES Cell International
- Essential Therapeutics
- EyeCyte
- Fate Therapeutics
- Garnet BioTherapeutics
- Genentech
- Genzyme
- Geron
- Gladstone Institute
- GlaxoSmithKline
- Goodwin Biotechnology
- Harvard
- Harvard Stem Cell Institute
- Hospira
- Incyte
- Institute for Regen. Med.at Wake Forest
- International Stem Cell
- Invitrogen
- InVivo Therapeutics
- iPierian
- Janssen
- Johns Hopkins
- Kings College
- Kyoto University
- Layton Bioscience
- LifeCell International
- Lifeline Cell Technology
- Lundbeck
- MacroPore Biosurgery
- Maret Pharma
- Medgenesis
- Medistem
- Medpace
- Medra
- Merck
- MetaCyte
- Millipore
- Mitsubishi
- NeoStem
- Neuralstem
- NeuroGeneration
- NeuroNascent
- NeuroNova
- Neuronyx
- NeuroSearch
- Neurotech Pharmaceuticals
- Neusentis
- Newron
- Novartis
- Novocell
- NsGene
- NuVasive
- Organogenesis
- Osiris
- PerkinElmer
- Pfizer
- PharmaStem Therapeutics
- PharmatrophiX
- Q Therapeutics
- Radius Ventures
- Ramot
- ReNeuron
- RhinoCyte
- Roche
- SanBio
- Scripps
- Sound Pharmaceuticals
- Stanford
- Stem Cell Sciences
- Stem Cell Therapeutics
- StemCell Technologies
- StemCells Inc
- StemCyte
- Stemedica
- StemLifeLine
- StemSource
- Taischo
- Targacept
- TCA Cellular Therapy
- Teva
- Theradigm
- Titan Pharmaceuticals
- University of Adelaide
- University of California Irvine
- University of California San Diego
- University of California San Francisco
- University of Massachusetts
- University of Minnesota
- University of Pennsylvania
- University of Pittsburg
- University of Utah
- University of Wisconsin
- ViaCell
- ViaCord
- Vista Cord
- WiCell

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.


If you have a more general question about our products please try our



Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.